Please join us in congratulating Renee Rollins for 20 years with Tennessee Oncology. #TennesseeOncology #Community #Oncology #Cancer
Tennessee Oncology
Hospitals and Health Care
Nashville, Tennessee 8,121 followers
Caring for Cancer Patients is a Privilege!
About us
Tennessee Oncology is one of the nation’s largest community-based cancer care specialists and home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high quality cancer care and the expertise of clinical research for all patients at convenient locations within their community and close to their home. To this day, our growing network of physicians and number of locations is based on this mission. In 2018, Tennessee Oncology joined OneOncology, a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the United States, as a founding practice partner. Physicians specializing in gynecologic oncology, palliative care, radiation oncology, and health psychology comprise our group. Tennessee Oncology provides a full range of diagnostic services, including oncology specific expertise in PET/CT and laboratory services. Clinic locations provide on-site chemotherapy treatments so that patients receive care in their community and close to their home. Our physicians utilize the latest in molecular diagnostics and profiling to choose treatments specific to the genetics of your cancer. Oncology research is the largest area of new drug development. Self -administered medications, those taken by mouth or injected by the patient, comprise approximately 40% of these investigative medications. Tennessee Oncology’s in house pharmacy, Park Pharmacy, stocks oncology and hematology medications not readily available at community retail pharmacies. A URAC accredited Specialty Pharmacy, Park provides insurance and benefits investigation, prior authorization services for insurance coverage, co-pay assistance through manufacturer or foundation programs, extensive medication education, and access to a pharmacist 24 hours a day, 7 days a week.
- Website
-
http://www.tnoncology.com
External link for Tennessee Oncology
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Nashville, Tennessee
- Type
- Self-Owned
- Founded
- 1976
- Specialties
- Oncology
Locations
-
Primary
2004 Hayes St
Nashville, Tennessee 37203, US
Employees at Tennessee Oncology
Updates
-
Dr. James R. Gray, MD and John Phillips of Tennessee Oncology have been named two of the country's best specialists by Newsweek. To read more on this momentous achievement, click the link below: https://loom.ly/HWdgswA #TennesseeOncology #Community #Oncology #Cancer
-
-
Each cancer diagnosis is unique, with its own complexities. At Tennessee Oncology Proton Center, our experienced specialists are well-prepared to navigate these challenges. We provide exceptional care, crafting personalized treatment plans for every patient. Trust us to be your partner on this journey. https://loom.ly/avjbk7I #TennesseeOncology #Community #Oncology #Cancer
-
-
Tennessee Oncology reposted this
Very excited to co-host the #IVBM event hosted by #AJMC in partnership with Tennessee Oncology on August 22, 2024, in Nashville, Tennessee. We're going to have amazing speakers to discuss topics such as innovation and entrepreneurship in large health systems and payer perspectives on value-based care. Register now and join me! https://lnkd.in/ezEUVnwB AJMC - The American Journal of Managed Care
-
-
Please join us in congratulating Christopher Dickens for 20 years with Tennessee Oncology. #TennesseeOncology #Community #Oncology #Cancer
-
-
Precision is key in effectively treating cancer. Proton Therapy offers a significant advantage over traditional methods by precisely delivering high-energy proton beams to destroy cancer cells, while sparing surrounding healthy tissue. This targeted approach is particularly beneficial for treating complex or hard-to-reach tumors. Discover how precision can make a difference in your treatment outcomes. https://loom.ly/FWN7P6w
-
Pfizer's Lung Cancer Drug Is Extending Survival Rates and Stopping Cancer Spread. An ongoing study showed that 60% of lung cancer patients who took a drug called Lorbrena remained alive and disease-free after five years. “After a five-year follow-up, we’ve not hit a median progression-free survival, which means it’s still 60% of the patients who are on [Lorbrena] continue to be on it,” Dr. Todd Bauer https://loom.ly/5KEDe0Y #TennesseeOncology #Community #Oncology #Cancer
-
-
Please join us in welcoming Dr. Wade Iams! Dr. Iams will be our new Director of Lung Cancer Research for the Greco Hainsworth Centers for Research. His primary clinic location will be at St. Thomas West. Dr. Iams earned his medical degree from the University of Michigan, was the Chief Resident at Vanderbilt University and conducted his fellowship in medical oncology at Northwestern University. He also achieved his master’s degree in Clinical Investigation from Vanderbilt University. Dr. Iams is a familiar face in Nashville as he was previously the Director of Thoracic Clinical Trials at Vanderbilt University Medical Center. Over his career, Dr. Iams has been the Site PI on no less than 16 phase I/II/II clinical trials. We are thrilled to have him help grow our research program and clinical excellence! #TennesseeOncology #Community #Oncology #Cancer #GHCR #ClinicalTrials
-
-
Rhiannon Dorris, PharmD, BCOP, BCPS was recently on a panel to discuss ‘Immunotherapy toxicities in CLL, myeloma, lymphoma’ as part of the hematological malignancies update at MLS (Master Lecture Series) Nashville: Review of 2024 ASCO. #TennesseeOncology #Community #Oncology #Cancer #ASCO
-
-
Tennessee Oncology reposted this
Excited to join Samyukta Mullangi and Debra Patt, MD PhD MBA for the Biden Cancer Moonshot conversation led by CMS this Thursday morning entitled 2024 Cancer Cabinet Community Conversation on System Transformation and Continuing to Increase Access to Patient Navigation Services. To tune in to our roundtable discussion, register here: https://lnkd.in/e64e2iKb